Table.
Screening criteria | Specificity (%) | Sensitivity (%) | Likelihood ratio if test negative | Likelihood ratio if test positive | Posterior probability if test negative* (%) | Posterior probability if test positive* (%) |
---|---|---|---|---|---|---|
Myocardial infarction† | 91 | 33 | 0.74 | 3.62 | 26 | 63 |
Electrocardiogram‡ | 87 | 41 | 0.68 | 3.13 | 24 | 60 |
Chest radiograph§ | 45 | 65 | 0.79 | 1.17 | 27 | 36 |
Brain natriuretic peptide¶ | 34 | 88 | 0.35 | 1.32 | 15 | 38 |
Myocardial infarction or | ||||||
Electrocardiogram | 82 | 61 | 0.48 | 3.29 | 19 | 61 |
Chest radiograph | 37 | 83 | 0.46 | 1.32 | 18 | 38 |
Brain natriuretic peptide | 27 | 90 | 0.38 | 1.23 | 15 | 37 |
Myocardial infarction or electrocardiogram or | ||||||
Chest radiograph | 31 | 83 | 0.53 | 1.22 | 20 | 36 |
Brain natriuretic peptide | 22 | 91 | 0.42 | 1.17 | 16 | 35 |
Myocardial infarction or chest radiograph or brain natriuretic peptide | 14 | 91 | 0.62 | 1.06 | 23 | 33 |
Any test | 11 | 92 | 0.78 | 1.03 | 27 | 33 |
Prevalence (prior probability) of left ventricular systolic dysfunction assumed to be 32%.
Positive if there is a history of myocardial infarction.
Positive if Q waves, bundle branch block, left ventricular hypertrophy, or T wave present.
Positive if pulmonary oedema or cardiomegaly present.
Positive if concentration >17.9 pg/ml.